NCT00510367View on ClinicalTrials.gov

Primary Breast Cancer Occurring Concomitant With Pregnancy

EARLY_PHASE1CompletedINTERVENTIONAL
Enrollment

61

Participants

Timeline

Start Date

August 7, 2001

Primary Completion Date

July 8, 2020

Study Completion Date

July 8, 2020

Conditions
Breast CancerPregnancy
Interventions
DRUG

5-Fluorouracil

500 mg/m\^2 By Vein Daily x 2 Days

DRUG

Cyclophosphamide

500 mg/m\^2 By Vein On Day 1

DRUG

Doxorubicin

50 mg/m\^2 By Vein Over 72 Hours

Trial Locations (1)

77030

University of Texas MD Anderson Cancer Center, Houston

All Listed Sponsors
lead

M.D. Anderson Cancer Center

OTHER

NCT00510367 - Primary Breast Cancer Occurring Concomitant With Pregnancy | Biotech Hunter | Biotech Hunter